This study looks at how people with Parkinson's disease use a medicine called ONAPGO™. ONAPGO™ is a type of treatment given through a small tube under the skin, called continuous subcutaneous infusion. It's important to know that this study will not change your treatment; it's just observing how people use this medicine. You'll have some visits with a Clinical Nurse Navigator (CNN), a nurse who helps with Parkinson's care. The study includes several periods: starting from when you get your prescription, learning how to use ONAPGO™, adjusting the dose, and then maintaining it.
- Participants must be prescribed ONAPGO™ and agree to work with a CNN.
- Participants will have education sessions and follow-up visits.
- People with certain allergies or taking specific other medicines can't join.
If you're interested, you need to talk to your healthcare provider, and they will decide if you’re the right fit. You will be asked to sign a consent form to join. This study is a chance to learn more about using ONAPGO™ in real-world settings.